Prespecified secondary analysis of 72,661 women aged 40-49: adding ultrasonography to mammography lowered cumulative incidence of stage 2+ breast cancer (HR 0.83; 95.6% CI 0.70-0.98) over a median 11.4 years; the difference was significant only between 48 and 96 months.
Secondary analysisn = 72,661
Harada-Shoji et al. Cumulative incidence of advanced breast cancer in women aged 40-49 years in the Japan Strategic Anti-cancer Randomised Trial (J-START) of adjunctive ultrasonography: a prespecified secondary analysis